Bringing the fundamentals into focus…
Back to Teva Pharmaceutical Industries Limited
How Teva Pharmaceutical Industries Limited stacks up
TEVA · against 60 other Healthcare companies of similar size
Valuation
55/ 100
Below the middle of the pack.
Ranked #37 of 61 · scores higher than 38% of peers
Bars: peers in each 10-point band of the valuation score15 peers with a valuation score of 50–59, including TEVA · Click a bar to see the companies
Why valuation scores 55?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- Earnings yield is close to the peer norm. Earnings yield: 1.4% vs peer median 1.5%
- more free cash flow for the price paid: stronger than 65% of peers. Free cash flow yield: 2.8% vs peer median 0.0%
- more operating profit (EBITDA) for the company's total value: stronger than 67% of peers. EBITDA yield: 6.9% vs peer median 4.0%
Metric by metric
Position: dot = TEVA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | TEVA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 58 reported | 1.4% | 3.0% | 14% | 30% | |
| EBITDA yieldHigher is better · 62 reported | 6.9% | 6.1% | 69% | 50% | |
| Free cash flow yieldHigher is better · 44 reported | 2.8% | 4.0% | 35% | 20% | |
| Book yieldHigher is better · 57 reported | 15.9% | 22.1% | 29% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around TEVA| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 4.61T JPY (≈$31.3B) | 93 | 76 | |
| 2 | 78.1B USD | 89 | 60 | |
| 3 | 97.5B USD | 87 | 67 | |
| 4 | 6.17T JPY (≈$42.0B) | 86 | 70 | |
| 5 | 45.9B USD | 84 | 61 | |
| 33 | 54.0B USD | 57 | 47 | |
| 33 | 31.3B USD | 57 | 63 | |
| 36 | 4.25T INR (≈$51.0B) | 56 | 70 | |
| 37 | 45.6B CHF (≈$52.4B) | 55 | 55 | |
| 37 | 48.9B USD | 55 | 54 | |
| 39 | 272.9B BRL (≈$49.1B) | 54 | 43 | |
| 40 | 49.5B USD | 53 | 53 | |
| 41 | 34.6B USD | 51 | 58 | |
| 41 | 34.0B USD | 51 | 49 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score